| Frederick Peter Spin, MD | |
|
590 Court St, Keene, NH 03431-1719 | |
| (603) 354-5454 | |
| Not Available |
| Full Name | Frederick Peter Spin |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine - Gastroenterology |
| Location | 590 Court St, Keene, New Hampshire |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1487687224 | NPI | - | NPPES |
| 30203424 | Medicaid | NH |
| Mailing Address | Practice Location Address |
|---|---|
| Frederick Peter Spin, MD 590 Court St, Keene, NH 03431-1719 Ph: (603) 354-5454 | Frederick Peter Spin, MD 590 Court St, Keene, NH 03431-1719 Ph: (603) 354-5454 |
News Archive
Janssen R&D Ireland (Janssen) announced today that two Phase 3 trials are recruiting patients to examine the efficacy and safety of the NS3/4A protease inhibitor simeprevir in combination with the nucleotide inhibitor sofosbuvir for the treatment of chronic genotype 1 hepatitis C virus (HCV) infection in treatment-naive and treatment-experienced patients with and without cirrhosis.
The Huntington Study Group (HSG), under the leadership of Ray Dorsey, M.D. with Johns Hopkins Medical and Diana Rosas, M.D. with Massachusetts General Hospital, is conducting a clinical trial in Huntington's disease (HD) throughout the United States and Australia, "A randomized, double-blind, placebo-controlled, study to assess the safety and tolerability, and efficacy of PBT2 in patients with early to mid-stage Huntington's disease" comparing a 100 mg dose or 250 mg dose versus placebo.
New evidence puts into doubt the long-standing belief that a deficiency in serotonin - a chemical messenger in the brain - plays a central role in depression. In the journal ACS Chemical Neuroscience, scientists report that mice lacking the ability to make serotonin in their brains (and thus should have been "depressed" by conventional wisdom) did not show depression-like symptoms.
The U.S. Food and Drug Administration today granted tentative approval for Basaglar (insulin glargine injection), which is indicated to improve glycemic control in adults with type 2 diabetes and in combination with mealtime insulin in adults and pediatric patients with type 1 diabetes.
› Verified 9 days ago
Dr. John G Schlegelmilch, M.D. Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 590 Court St, Keene, NH 03431 Phone: 603-354-5450 | |
Dr. Sherry Ann Guardiano, D.O. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 590 Court St, Keene, NH 03431 Phone: 603-354-5454 | |
Dr. Roy Rajan, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 590 Court St, Keene, NH 03431 Phone: 603-354-5400 | |
Daniel L Rath, M.D. Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 590 Court St, Keene, NH 03431 Phone: 603-354-5400 Fax: 603-354-5429 | |
Ethan Karle, Gastroenterology Medicare: Medicare Enrolled Practice Location: 580 Court St, Keene, NH 03431 Phone: 603-354-5400 | |
Dr. Steven Sigurd Larmon, MD Gastroenterology Medicare: Medicare Enrolled Practice Location: 590 Court St, Keene, NH 03431 Phone: 603-354-5454 | |
Dr. Andrew C Gorske, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 590 Court St, Dartmouth Hitchcock - Gastroenterology, Keene, NH 03431 Phone: 603-354-6534 |